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Maintaining cell-cell adhesions of keratinocytes is crucial in tightly packing 
the cells in the epithelium and protecting tissues underlying epithelium 
against harmful agents such as microorganisms or toxins. E-cadherin 
junctions (ECJs) have a major role in keeping the integrity of adhesion 
complex of oral keratinocytes. Therefore understanding of the molecular 
mechanisms of their formation is critical in both normal and transformed oral 
keratinocytes. First, HOK-16B cells, a normal human gingival epithelial cell 
line, were used to identify the molecules involved in the regulation of the 
formation of intercellular E-cadherin junctions between human gingival 
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epithelial cells. Activation of c-Jun N-terminal kinase (JNK) disrupted the 
intercellular junctions through the dissociation of E-cadherin. The role of 
JNK in the formation of these E-cadherin junctions was further confirmed 
by demonstrating that JNK inhibition induced the formation of intercellular 
E-cadherin junctions. The upstream signaling of JNK was also examined. 
Activation of the small GTPase RhoA disrupted the formation of E-cadherin 
junctions between HOK-16B cells, which was accompanied by JNK 
activation. Disruption of these intercellular junctions upon RhoA activation 
was prevented when JNK activity was inhibited. In contrast, RhoA 
inactivation led to HOK-16B cell aggregation and the formation of 
intercellular junctions, even under conditions in which the cellular junctions 
were naturally disrupted by growth on a strongly adhesive surface. Then, 
the JNK-dependent regulation of E-cadherin junction was confirmed in 
gingival epithelium including junctional epithelium (JE) of which intercellular 
junction is poorly formed. Expectedly, JE of mouse molars had high JNK 
activity associated with low E-cadherin expression, which was reversed in 
the other gingival epithelia, including the sulcular epithelium. Next, the 
molecular mechanism by which squamous cell carcinoma cells grow 
scattered at the early phase of transformation while maintaining the 
epithelial phenotype was studied because cell scattering of epithelial 
carcinoma cancer cells is one of the critical event in tumorigenesis. Cells 
losing epithelial cohesion detach from aggregated epithelial cell masses and 
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may migrate to fatal organs through metastasis. YD-10B cells which are 
established from human oral squamous cell carcinoma was studied because 
the cells grow scattered without the formation of ECJs under routine culture 
conditions despite the high expression of functional E-cadherin. The 
functionality of their E-cadherin was demonstrated in that YD-10B cells 
formed ECJs, transiently or persistently, when they were cultured on 
substrates coated with a low amount of fibronectin or to confluence. The 
phosphorylation of JNK was up-regulated in YD-10B cells compared with 
that in human normal oral keratinocyte cells or human squamous cell 
carcinoma cells, which grew aggregated along with well-organized ECJs. 
The suppression of JNK activity induced the aggregated growth of YD-10B 
cells concomitant with the development of ECJs. These results indicate that 
the decreased formation of intercellular E-cadherin junctions between 
human gingival keratinocytes may be coupled to high JNK activity and the 
inherently up-regulated JNK activity induces the scattered growth of the 
oral squamous cell carcinoma cells through disassembly of ECJ despite the 
expression of functional E-cadherin, a hallmark of the epithelial phenotype. 
―――――――――――――――――――――――――――――――――――― 
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E-cadherin also called as cadherin-1 or CAM 120/80 is a protein encoded 
by the CDH1 gene which is a tumor suppressor gene [1-3]. E-cadherin is a 
cell-cell adhesion glycoprotein which is calcium-dependent. It is expressed 
in various epithelial cells including oral keratinocytes [4]. It contributes to the 
formation of an epithelial barrier sealing the intercellular junction against the 
invasion of microorganisms or toxins  The extracellular domain of E-
cadherin mediates bacterial adhesion to epithelial cells [5]. The intracellular 
domain has a highly-phosphorylated region which is critical in β-catenin 
binding to E-cadherin. α-catenin binding to β-catenin play a part in 
regulating the assembly of F-actins [6]. Mutations in this gene are associated 
with various epithelial cancers such as breast, gastric, colorectal, ovarian, and 
thyroid cancers. Loss of function of E-cadherin increases proliferation, 
invasion, and/or metastasis which contribute to the cancer progression and 
metastasis. Down-regulation of E-cadherin expression decreases the 
strength of cell-cell adhesion, resulting in an increased cellular motility [7-
11]. 
 
2. c-Jun N-terminal kinases (JNKs) 
The c-Jun N-terminal kinases (JNKs) are a member of the mitogen-
activated protein kinase family. They are activated in responses to various 
stress stimuli, such as ultraviolet irradiation [12], cytokines[13], osmotic 
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shock [14], reactive oxygen species, inflammatory signals, protein synthesis 
inhibitors, and heat shock [15, 16]. Inhibition of phosphatases also inhibit the 
activity of JNK and its downstream. They are associated with the pathways 
involving in cellular apoptosis and T cell differentiation. JNKs are activated 
through a dual phosphorylation of threonine and tyrosine residues in kinase 
subdomain VIII by MKK4 or MKK7. Ser/Thr or Tyr protein phosphatases 
inactivates JNKs [17]. Ten JNKs isoforms of 46 kDa or 55 kDa are derived 
from three genes: four isoforms of JNK1, four isoforms of JNK2 and two 
isoforms of JNK3. Both JNK1 and JNK2 are expressed in all cells and tissues, 
whereas JNK3 is found in the brain, heart, and the testes [18, 19]. 
 
3. Ras homolog gene family, member A (RhoA) 
Ras homolog gene family, member A (RhoA), a small GTPase, is one of 
Rho family. Active RhoA regulates cytoskeleton, especially development of 
actin stress fibers and contractility of actomyosin. In addition, RhoA activity is 
associated with cell cycle progression, transcription, and cell transformation. 
RhoA is activated by various guanine nucleotide exchange factors (GEFs) 
through phosphorylation [20]. The GTP-bound RhoA through exchanging of 
GDP to GTP activates RhoA. There are several effectors of RhoA including 
ROCK1 (Rho-associated, coiled-coil containing protein kinase 1) and 
DIAPH1 (Diaphanous Homologue 1, a.k.a. hDia1, diaphanous in Drosophila, 
homologue to mDia1 in mouse). Activated RhoA stimulates Rho-associated 
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kinase (ROCK) - LIM kinase which then activates cofilin. Next, cofilin 
reorganizes the F-actin. Among various functions involved in RhoA activity, 
RhoA directly polymerizes F-actin through the activation of mDia1. ROCK 
contracts actomyosin through regulating myosins and various actin-binding 
proteins, which regulating cell migration and detachment [21]. RhoA activity 
is also associated with cell-cell adhesions, primarily in adherens or tight 
junctions [22, 23]. 
 
4. Gingival junctional epithelium 
Junctional epithelium (JE) seals the interface between the oral cavity and 
the underlying connective tissue. JE is unique in that it contacts with the solid 
surface of the tooth. It is a junction of a potential weakness through which 
bacterial products enter the connective tissue eliciting inflammation. JE is 
localized under the bottom of the gingival sulcus to the tooth apex. Epithelium 
of JE is different from those of the sulcus. Oral sulcular epithelium is lined by 
typical oral epithelium which is a nonkeratinized stratified squamous epithelium 
of tight intercellular junction. However, JE is a nonkeratinized stratified 
squamous epithelium of loose intercellular junction which contacts both lamina 
propria of gingiva and tooth surface simultaneously [24-26]. The cells in the 
JE uniquely presents a morphology of incompletely differentiated epithelium. 
Tonofilaments and desmosomal junctions in the JE cells are fewer. K5, K8, 
K14, K18, K19 cytokeratins are found in the JE cells which are localized in 
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basal epithelial cells or simple epithelia [27, 28]. In addition, striking wide 
intercellular space may be associated with the permeability of JE, which may 
explain the presence of infiltrating leukocytes in JE [25]. 
 
5. Purpose of this study  
The main purpose of this study is to investigate the signaling mechanisms to 
identify the regulation of development of intercellular junctions in oral gingival 
keratinocytes and oral squamous carcinoma cells. To achieve this goal, I 
examined the effect of controlling the formation of the E-cadherin junctions 
1) regulated by the interaction between RhoA and JNK signaling on fibronectin 
smooth/rough surface in normal oral keratinocytes, and 2) in oral squamous 
cell carcinoma (OSCC) cells. Next, I verified the differences of the signaling 
regulations between normal oral keratinocytes and carcinoma cells. Finally, I 
detected to establish a model cell line, which grow scattered affected by the 
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The junctional epithelium (JE) forms a seal between tooth and gingiva, where 
it functions as a barrier against attack by microorganisms or toxic substances 
[25, 26]. However, the JE does not provide an appropriate protective epithelial 
barrier due to its structure. Its intercellular junctions are poorly developed and 
sparse, and its intercellular space is wide compared with that of the gingival 
epithelium (GE), which is tightly packed with well-developed intercellular 
junctions. Thus, bacterial toxins or bacteria may invade these wider spaces, 
resulting in gingivitis. If bacteria further invade this vulnerable barrier, the 
barrier will be irreversibly destroyed through induction of subepithelial 
inflammation. Here, the inflammatory response in connective tissue produces 
inflammatory cytokines, which further deteriorate the epithelial defense 
barrier established by the JE. Therefore, understanding the mechanisms that 
maintain the structural integrity of the JE is essential in preventing and treating 
gingivitis and periodontitis. 
The structural weakness of the intercellular junctions within the JE suggests 
that the mechanism regulating these junctions is defective. In this study, the 
molecular features associated with the development of intercellular E-
cadherin junctions were analyzed to determine what factors lead to the poor 
development of intercellular junctions between oral keratinocytes. E-cadherin 
is the major adhesion molecule connecting epithelial cells within the JE [29] 
and is localized at the desmosome of the epithelium [30-33], which provides 
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strong adhesion between epithelial cells. In addition, E-cadherin is regarded 
as a crucial molecular component within the organization of the desmosomal 
molecular complex [30-33]. For example, the E-cadherin-plakoglobin 
complex is required for desmosome organization [34]. E-cadherin is also 
critical in maintaining the structural integrity of the oral epithelium [26, 29]. 
Recently, c-JUN NH3-terminal kinase (JNK) was shown to be involved in 
negatively regulating the formation of intercellular E-cadherin junctions [35, 
36]. Active JNK phosphorylates β-catenin to prevent E-cadherin 
complexes from forming. In the present study, human oral keratinocytes were 
analyzed to determine whether the formation of their intercellular E-cadherin 
junctions is dependent on JNK activity and which molecular control 
mechanisms regulate this activity. Understanding the molecular mechanisms 
controlling the formation of intercellular junctions between oral epithelial 
keratinocytes may provide insight into the poor development of these junctions 









ii. MATERIALS AND METHODS 
 
1. Reagents 
The following antibodies for Western blotting were purchased from Cell 
Signaling Technology (Danvers, MA, USA): rabbit anti-JNK, rabbit anti-
phospho-JNK (Thr183/Tyr185), rabbit anti-E-cadherin, rabbit anti-
GAPDH, and HRP-linked anti-rabbit IgG. Anti-phospho-myosin light chain 
(p-MLC) was purchased from Millipore (Darmstadt, Germany). Rabbit anti-
E-cadherin and rabbit anti-phospho-JNK for immunocytochemistry studies 
were also obtained from Cell Signaling Technology. Cy™3-conjugated 
AffiniPure goat anti-rabbit IgG (H+L) (Cy3-IgG) was purchased from 
Jackson Immunoresearch Laboratories (West Grove, PA, USA). Antiserum 
against odontogenic ameloblast-associated protein (ODAM) (Nishio et al. 
2010) was a gift from Dr. Joo-Cheol Park (Seoul National University, Seoul 
Korea). SP600125 (JNK inhibitor), SB203580 (p38 inhibitor), U0126 (ERK 
inhibitor), fluorescein isothiocyanate-labeled phalloidin (phalloidin-FITC), 
and 4′,6-diamidino-2-phenylindole dihydrochloride (DAPI) were obtained 
from Sigma-Aldrich (St. Louis, MO, USA). Exoenzyme C3 transferase from 
Clostridium Botulinum (C3; RhoA inhibitor) and CNF-1 (RhoA activator) were 
obtained from Cytoskeleton (Denver, CO, USA). Col-Tgel was purchased 




2. Preparation of culture dish surfaces 
Two different concentrations of fibronectin (Sigma-Aldrich) were used to 
coat hydrophobic petri dishes to allow for HOK-16B cell growth as a typical 
confluent epithelial layer (0.1 µg/cm2 fibronectin) or as a scattered cell layer 
(1 µg/cm2 fibronectin) at 37°C for 2 h. Laminin (Engelbreth-Holm-Swarm 
murine sarcoma basement membrane, Sigma-Aldrich; 1 µg/cm2) was also 
coated onto the dishes for the scattered cell growth experiments. Dishes were 
then washed with PBS, blocked with 5% BSA for 1 h at 37°C, washed again 
with PBS, and kept at 4°C until use. Collagen gel surfaces were prepared by 
pouring a mixture of Col-Tgel component A and component B (20:1 v/v) onto 
culture dishes and incubating at 37°C for 45 min. Solidified gel surfaces were 
coated with 1 µg/cm2 of fibronectin for 1 h. Dishes were then washed with 
PBS. 
 
3. Cell culture  
HOK-16B cells from retromolar tissue were a gift from Dr. N-H Park 
(University of California, Los Angeles, USA) (Park et al. 1991). The cells 
were grown in KGM keratinocyte growth media supplemented with bovine 
pituitary extract, GA-1000 (gentamicin, amphotericin-B), hydrocortisone, 






pcDNA3-RhoA-Q63L (constitutively active RhoA: RhoA-CA), pcDNA3-
RhoA-T19N (dominant-negative RhoA: RhoA-DN), pcDNA3-Flag-
MKK7b2-JNK1a1 (constitutively active JNK1), pcDNA3-Flag-MKK7b2-
JNK2a2 (constitutively active JNK2), the lentiviral vector pCS-CG were 
purchased from Addgene (Cambridge, MA, USA). Lipofectamine LTX reagent 
and Plus™ reagent were purchased from Invitrogen (Carlsbad, CA, USA). 
Lentiviral vector M1.4, virus packaging vector psPAX2, and envelope protein 
vector pMD2G were gifts from Dr. Zang-Hee Lee (Seoul National University, 
Seoul Korea). M1.4-RhoA-CA, M1.4-RhoA-DN, pCS-CG-MKK7b2-
JNK1a1, and pCS-CG-MKK7b2-JNK2a2 were generated by Cosmo 
Genetech (Seoul, Korea). JNK1 shRNA (shJNK1) plasmid for lentiviral 
transfections was purchased from Santa Cruz Biotechnology (Santa Cruz, CA, 
USA). HEK293T cells (a gift from Dr. Z-H Lee) were transfected with 
recombinant vector, psPAX2, and pMD2G simultaneously using Lipofectamine 
LTX and Plus™ reagents. Lentiviruses generated by the transfected HEK293T 
cells were used to infect HOK-16B cells. Cells were selected by treating with 
puromycin. 
 
5. Tissue preparation and immunohistochemistry 
All experiments using animals followed protocols approved by the Institutional 
Animal Care and Use Committee of Seoul National University (SNU-140828-
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1). Twelve-week-old C57BL/6 mice were euthanized by asphyxiation in 
carbon dioxide. Mandibular molars, including surrounding tissues, were 
excised and fixed with 4% phosphate-buffered paraformaldehyde. Tissues 
decalcified in a solution of 10% EDTA (pH 7.4) were embedded in paraffin. 
The deparaffinized sections, treated with a citrate buffer (pH6.0) for antigen 
retrieval in a microwave oven, were incubated with primary antibodies against 
E-cadherin or p-JNK overnight at 4°C. These sections were further incubated 
with Cy3-IgG and examined using a LSM 700 confocal laser-scanning 
microscope (Zeiss; Oberkochen, Germany). Sections processed without 




HOK-16B cells were fixed with 4% w/v paraformaldehyde and permeabilized 
in 0.5% v/v Triton X-100. The cells were then incubated with primary 
antibodies against E-cadherin. Finally, cells were treated with Cy3-IgG. F-
actin was stained with phalloidin-FITC. Images were acquired using a LSM 
700 confocal laser-scanning microscope. 
 
7. Statistical analyses 
The data represent the mean ± standard deviation of at least three samples. 
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Statistical analyses were performed using a t-test for normally distributed 
data or a signed rank sum test for non-normally distributed data. P values less 






1. JNK activity is critical to the formation of intercellular E-cadherin 
junctions between human oral keratinocytes 
HOK-16B cells formed a typical confluent epithelial layer and well-organized 
junctions expressing a high level of E-cadherin (Fig 1A). We altered JNK 
activity to determine whether it was required for the formation of E-cadherin 
junctions between human oral keratinocytes. The pharmacological activation 
of JNK with anisomycin and the constitutive activation of the MKK7b2-
JNK1a1 fusion protein decreased E-cadherin expression at the cell junctions, 
leading to intercellular dissociations (Fig 1A and B). Treatment of cells with 
the JNK inhibitor SP600125 prior to treatment with anisomycin eliminated the 
effect of anisomycin; pretreatment with SB203580, a p38 inhibitor, did not. 
These results indicate that JNK activity, not p38 activity, disrupts the 
formation of E-cadherin junctions (Fig 1A). JNK regulation of E-cadherin 
was further confirmed by demonstrating that the intercellular junctions 
between HOK-16B cells could be restored by downregulating JNK activity, 
even in conditions where the cell junctions were naturally disrupted by growth 
on strongly adhesive surfaces. HOK-16B cells, which had grown scattered on 
dishes coated with large amounts of laminin or fibronectin (data not shown) 
and did not develop E-cadherin junctions, formed a typical confluent epithelial 
layer when JNK activity was inhibited by SP600125 or when cells were 
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expressed shJNK1 (Fig 1C and D). However, JNK did not regulate the 
expression level of E-cadherin in these experimental conditions (Fig 6). 
Moreover, other types of MAPKs, such as ERK and p38, were not associated 
with the formation of E-cadherin junctions (Fig 7). These results indicate that 
JNK activity is specifically associated with the formation of intercellular E-
cadherin junctions between human oral keratinocytes. 
 
2. RhoA activity disrupts the intercellular junctions between human oral 
keratinocytes 
RhoA controls the dynamics of actin filaments, which are one of the major 
components of E-cadherin junctions. It has also recently been reported to 
regulate various essential cell activities, such as proliferation and cell survival, 
in addition to cell migration and the formation of stress fibers [37-39]. 
Furthermore, RhoA is reportedly associated with the various functions of cell 
junctions. Rho GTPases remodel actin-based structures on endothelial cells 
to facilitate the migration of leukocytes through the junctions between 
endothelial cells. RhoA activation also increases the permeability of junctions 
between endothelial cells [40, 41]. Based on these reports, we examined the 
role of RhoA in regulating the formation of E-cadherin junctions between 
human oral keratinocytes. CNF-1, a specific RhoA activator, downregulated 
E-cadherin expression at the intercellular junctions, widening the gaps 
between neighboring cells (Fig 2A). Constitutive activation of RhoA also 
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dissociated the cell junctions (Fig 2B). To confirm the function of RhoA as a 
negative regulator of intercellular junctions, HOK-16B cells growing in a 
scattered pattern were treated with C3, a specific RhoA inhibitor, in petri 
dishes coated with a large amount of fibronectin (a highly adhesive surface). 
Upon treatment with C3, the cells aggregated to form a confluent epithelial 
layer, accompanied by the formation of intercellular E-cadherin junctions (Fig 
2C). The dominant-negative inhibition of RhoA activity also induced cells to 
develop E-cadherin junctions, even when cultured on a highly adhesive 
surface (Fig 2D). Taken together, these results indicate that RhoA is a 
negative regulator of intercellular E-cadherin junctions. 
 
3. RhoA disrupts the intercellular E-cadherin junctions between human 
oral keratinocytes by activating JNK 
RhoA activation induced by treating cells with CNF-1 or by transfecting the 
cells with a viral vector expressing RhoA-CA upregulated JNK 
phosphorylation (Fig 3A and B). In contrast, RhoA inhibition induced by 
treating cells with C3 or by transfecting them with a viral vector expressing 
RhoA-DN downregulated JNK phosphorylation (Fig 3C and D). Furthermore, 
disruption of the intercellular junctions resulting from RhoA activation was 
completely blocked when cells were pretreated with the JNK inhibitor 
SP600125 (Fig 3E and F). These results suggest that JNK functions at a 
downstream point in the RhoA signaling pathway to disrupt the intercellular 
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junctions between human oral keratinocytes. 
 
4. JNK is highly active in junctional epithelial cells, but E-cadherin 
expression within the intercellular junctions of these cells is low 
The p-JNK and E-cadherin expression were detected in the JE and the GE 
to confirm the presence of an inverse relationship between their expression 
levels. The JE of mouse molars was identified by the expression of ODAM [42] 
and by its specific ultrastructural phenotype (Fig 8). Immunohistochemical 
analysis of the JE showed that the expression level of E-cadherin within the 
intercellular junctions was substantially lower than that shown for the GE (Fig 
4). The low expression of E-cadherin within the JE is common among 
different species. E-cadherin expression is reported to be lower in the JE in 
humans as well [29]. As expected, expression levels of p-JNK were higher 
in the JE than in the GE (Fig 4). These results suggest that higher JNK activity 
may be associated with the poor development of E-cadherin junctions within 
the JE. 
 
5. In vitro formation of the intercellular E-cadherin junctions between 




The JE is unusual in that it attaches to the surface of enamel, which is the 
hardest surface in the human body. Attachment to this surface may be enabled 
through special characteristics of the JE not found in other epithelium. 
Intercellular junctions between human oral keratinocytes were compared after 
culturing on flexible collagen gel or in solid polystyrene culture dishes, both of 
which were coated with a high concentration of fibronectin which disrupt the 
intercellular junctions. Interestingly, cells cultured on the collagen gels 
maintained their E-cadherin junctions (Fig 5A). However, HOK-16B cells 
cultured on the stiff surface of the culture dishes lost their intercellular 
connections. These results indicate that a stiff surface may induce the 
activation of a RhoA-JNK signaling pathway that leads to the disruption of the 
intercellular E-cadherin junctions. As expected, the level of active 
phosphorylated JNK was higher in cells grown on the stiff culture dishes 
compared with those grown on the softer collagen surface (Fig 5B). JNK 
activation by anisomycin disrupted the intercellular E-cadherin junctions 
formed between cells on the collagen gel surfaces. In contrast, JNK inhibition 
by SP600125 restored these junctions on the stiff culture dishes. Because 
RhoA activity could not be directly analyzed due to the cytoskeletal 
modifications that would occur during cell detachment from the gel matrix, 
lower RhoA activity on the soft gel surfaces was confirmed by examining the 
phenotypical changes induced when activating RhoA. RhoA activation by CNF-
1 disrupted the intercellular E-cadherin junctions between cells grown on the 
collagen gel surface. In contrast, RhoA inhibition by C3 restored the junctions 
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between cells grown in the stiff culture dishes. These results suggest that the 
stiffness of the surface to which epithelial cells attach and grow may reduce 
the stability of the intercellular junctions between cells through activation of 
RhoA-JNK signaling. Thus, it is highly probable that intercellular junctions 
within the JE are poorly formed as a result of the underlying, highly solid 
enamel surface. 
 
6. Role of JNK in ECJ development in HGKs cultured on rough surfaces 
Cells seeded on the rough surface with mid- (R(4000)) or high- 
nanometer dimensions (R(1200)) barely developed E-cadherin junctions 
between cells (Fig 10A). As in above results, JNK was shown to downregulate 
the ECJ development in HGKs. Therefore, it was examined whether defective 
ECJ development in the cells cultured on the rough substrates was associated 
with JNK activity. The expression level of p-JNK was assessed by 
immunoblotting for p-JNK in cells cultured on substrates with varying levels 
of roughness. The expression levels of p-JNK were higher in the cells 
cultured on the rough substrates than in the cells cultured on the smooth 
substrate (Fig 10E). 
    JE migrates apically with age. Therefore substrates to which JE attach 
switch from the smooth enamel surface to the rough cementum surface. Softer 
cementum surface provides rougher substrates to JE attachment. In addition, 
deeper scratches made on the soft cementum and dentin by mechanical 
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periodontal treatments such as root planning or scaling generate much rougher 
substrates to JE attachment. Thus the development of the intercellular E-
cadherin junctions was examined on the rough substrates. As being expected, 
the highly defective E-cadherin junctions developed concomitant with the 
increased JNK activity on rough substrates.  
    Next, the effect of JNK inhibition on ECJ development was examined. The 
treatment of the cells with SP600125, a pharmacological inhibitor of JNK, 
clearly promoted ECJ development in the HGKs cultured on the rough 
substrate with low-nanometer dimensions and on the smooth substrate (Fig 
10B). The knockdown of JNK1 or JNK2 via lentiviral transfection of shRNA 
JNK1 or shRNA JNK2 into the cells also promoted ECJ development in HGKs 
cultured on the rough substrate with low-nanometer dimensions (Fig 10C). In 
addition, involvement of JNK in the regulation of ECJ development was further 
confirmed by showing that anisomycin, a pharmacological activator of JNK, 
disrupted the ECJs of the cell aggregates (Fig 10D). These results suggest 
that the delay in ECJ development may have been associated with JNK activity 
in the cells cultured on the rough substrate with low-nanometer dimensions. 
However, the responsiveness of ECJ development to JNK regulation was 
observed in HGKs cultured on the rough substrate with a low-nanometer 
dimension, but not in HGKs cultured on substrates with higher levels of 
roughness. There was no acceleration of ECJ development in response to JNK 
inhibition in the cells grown on substrates with higher levels of roughness (Fig 
10B). These results indicate that the physical barrier of the very rough 
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substrates could not be overcome by the biological regulation of JNK activity 
when the cells were scattered at a low density. However, ECJ development in 
response to JNK inhibition in the cells grown on the substrates with greater 
levels of roughness was clearly upregulated when the cells were cultured at a 
high density to reduce the distance between cells. These results suggest that 
JNK inhibition can be used to promote ECJ development when oral 








The present study demonstrates that the formation of cell-to-cell 
junctions between human oral keratinocytes is regulated by cell signaling 
pathways. Therefore, the structural characteristics of the JE may be derived 
from differences in the signaling pathways controlling the intercellular 
junctions. The JE of mouse molars contained high JNK activity accompanied 
by poorly formed E-cadherin junctions. This inverse relationship between the 
development of the intercellular junctions and JNK activity were apparent in 
vitro. JNK activation downregulated E-cadherin expression at the site of the 
disrupted cellular junctions. These results strongly suggest that the poor 
development of intercellular E-cadherin junctions within the JE may be a 
result of high JNK activity. The dissociation of cell-to-cell junctions between 
oral keratinocytes may lead to a deterioration of the protective barrier 
provided by the oral epithelium against bacterial invasion or the diffusion of 
toxic substances, which ultimately leads to infection or inflammation of the 
connective tissue underlying the epithelium. It has been reported that E-
cadherin expression decreases further within the pocket epithelium compared 
with the healthy JE [29]. These results indicate that JNK may be a master 
signaling molecule regulating the intercellular junctions within the JE. 
Furthermore, it is possible that JNK inhibition may prevent or treat gingivitis 
and periodontitis by promoting the strengthening of the intercellular junctions. 
   The JE is peculiar in that it has two basal laminae, one opposing the gingival 
connective tissue and the other opposing the solid enamel surface. 
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Interestingly, the JE interfaces with enamel, which is the stiffest surface in the 
human body. Thus, we hypothesized that the solid enamel surface may 
promote dissociation of E-cadherin junctions within the JE. To this end, we 
compared the cellular junctions between human oral keratinocytes cultured on 
stiff culture dishes to those formed on soft collagen gels. Dissociation of human 
oral keratinocytes from the culture dishes strongly points to the poor formation 
of intercellular E-cadherin junctions. Furthermore, this dissociation was 
associated with higher JNK and RhoA activities compared with the confluent 
layer of cells formed on the soft collagen gels. Based on these results, we 
conclude that the stiffness of a surface leads to the upregulation of RhoA, 
which in turn activates JNK, resulting in disruption of the intercellular junctions 
within the JE (Fig 9). The poor formation of adherens junctions between 
human skin keratinocytes grown on stiff surfaces further supports our 
hypothesis [43]. Studies using a conditional JNK or RhoA knockdown animal 
model will be required to confirm this hypothesis.  
   Also, we hypothesized that the solid and rough dentin surface can be 
affected to the junctional epithelial cells in case of which the periodontal pocket 
is getting deeper. Thus we compared the intercellular E-cadherin junctions 
with smooth and rough substrates. The development of E-cadherin junctions 
on rough substrate was defected and this disassembly of intercellular junction 
was affected by JNK activity. However, RhoA signaling on rough substrate is 
needed to be more investigated. 
   The finding that RhoA plays a role in regulating the intercellular junctions 
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between oral keratinocytes by activating JNK is notable because various 
bacterial toxins regulate RhoA activity. Therefore, it is likely that the E-
cadherin junctions within the JE may be further destroyed if bacterial toxins 
also activate RhoA-JNK signaling. Although it is unknown whether oral 
bacteria regulate RhoA, it is well known that many bacteria secrete toxins that 
affect RhoA activity. CNF-1, used to activate RhoA in this study, is a 115-
kDa toxin that is produced by uropathogenic Escherichia coli [44]. PMT, used 
to activate JNK (data not shown), is a 146-kDa toxin produced by Pasteurella 
multocida, the bacteria responsible for pasteurellosis, bite-wound 
dermonecrosis, and rhinitis in animals [45]. Exoenzyme C3, used in the 
present study to downregulate RhoA activity, is a 26-kDa molecule with 
ADP-ribosyltransferase activity that is produced by various bacteria including 
Clostridium botulinum, Clostridium limosum, Staphylococcus aureus, and 
Bacillus cereus [46]. 
    In summary, the present study suggests that RhoA-JNK signaling may be 
associated with the structural defects of human oral keratinocyte intercellular 
junctions. However, inhibition of the RhoA-JNK signaling axis may ultimately 
be a way in which to strengthen these intercellular junctions. In fact, further 
study of this signaling axis may explain why the JE contains cells with wide 
intercellular junctions that are sparsely populated with E-cadherin and may 
suggest ways in which to strengthen the junctions to protect tooth-supporting 























Figure 1. JNK regulates the formation of intercellular E-cadherin 
junctions between HOK-16B cells in vitro. The formation of E-cadherin 
junctions was determined by examining the expression level of E-cadherin 
(upper panels). F-actin was stained with FITC-phalloidin (lower panels). (A) 
Cells were treated with anisomycin, an activator of both JNK and p38 which 
had been pretreated with SB203580 (15 μM) or SP600125 (1 μM) to inhibit 
p38 activity or JNK activity respectively. Cells were cultured for 6 h. (B) Cells 
expressing constitutively active JNK1 were cultured for 2 days (left panel). 
Constitutive activation of exogenous JNK was confirmed by Western blotting 
(right panel). (C) Cells that grew in a scattered pattern on the laminin-coated 
hydrophobic dishes were treated with SP600125 (1 μM) for 24 h to inhibit 
JNK activity. (D) Cells infected with lentiviruses expressing shJNK to 
selectively inhibit JNK1 expression were cultured on laminin-coated 







Figure 2. RhoA inhibits the formation of intercellular E-cadherin 
junctions between HOK-16B cells in vitro. The formation of E-cadherin 
junctions was determined by examining the expression level of E-cadherin 
(upper panel of each picture). F-actin was stained with FITC-phalloidin 




E-cadherin junctions was examined. Cells were cultured on fibronectin-
coated plates containing 0.1 µg/cm2 fibronectin, which allowed cells to form 
intercellular junctions. RhoA activity was upregulated by treating cells with 
CNF-1 (0.5 μg/ml) for 24 h (A). Cells infected with lentiviruses expressing 
RhoA-CA were cultured for 24 h (B). (C and D) The effect of RhoA 
inactivation on the intercellular junctions was examined. Cells were cultured 
on fibronectin-coated plates containing 1 µg/cm2 fibronectin, which forced 
cells to grow in a scattered pattern without forming intercellular junctions. 
Cells were then treated with C3 for 6 h to inhibit RhoA activity (C). Cells 
infected with lentiviruses expressing RhoA-DN were cultured for 24 h (D). 














Figure 3. RhoA regulates the formation of intercellular E-cadherin 
junctions between HOK-16B cells by controlling JNK activity. (A - D) 
Regulation of JNK phosphorylation by RhoA was examined by Western blot 
analysis of cell lysates. p-MLC was also analyzed to confirm RhoA activity. 
Cells cultured on fibronectin-coated plates containing 0.1 µg/cm2 fibronectin, 
which allowed cells to form intercellular junctions, were treated with the RhoA 




expressing RhoA-CA were cultured for 24 h. (C) Cells cultured on 
fibronectin-coated plates containing 1 µg/cm2 fibronectin, which forced cells 
to grow in a scattered pattern without forming intercellular junctions, were 
treated with the RhoA inhibitor C3 (0.5 µg/ml) for 6 h. (D) Cells infected with 
lentiviruses expressing RhoA-DN were cultured for 24 h. (E-F) The 
formation of E-cadherin junctions was determined by examining the 
expression of E-cadherin (upper panels). F-actin was stained with FITC-
phalloidin (lower panels). Cells pre-treated with SP600125 (1 μM) for 1 h 
or left untreated were additionally treated with the RhoA activator CNF-1 (1 
μM) for 24 h to determine whether JNK was regulated by RhoA (E). Cells 
expressing RhoA-CA were seeded onto culture dishes and grown in the 






Figure 4. p-JNK is highly expressed within the intercellular junctions of 
the mouse junctional epithelium, whereas E-cadherin is poorly 
expressed. (A) Decalcified paraffin sections of mandibular molars, including 
surrounding tissue, were immunostained using antibodies against E-cadherin 
or p-JNK. Nuclei were stained with DAPI. In addition, E-cadherin expression 
levels following JNK inhibition were also examined. Dashed lines indicate the 
outline of the JE. Scale bar, 50 μm. (B) Relative intensity of the expression 




dividing the intensity of the JE by the sum of the intensities of the JE and GE 
combined. Relative intensity of the GE was obtained by dividing the intensity 
of the GE by the sum of the intensities of the JE and GE. The data are 
expressed as the mean ± SD. n = 5. Each immunohistochemical datum was 

















Figure 5. Intercellular E-cadherin junctions between HOK-16B cells 
are poorly formed due to the upregulation of p-JNK that results from 
growth on solid surfaces. (A) Cells were grown on polystyrene culture 
dishes or on soft collagen gels (coated with fibronectin, 1 µg/cm2) for 24 h. 
Cells on the collagen gels were subsequently treated with anisomycin (1 μM) 




on the culture dishes were subsequently treated with SP600125 (1 μM) or 
C3 (0.5 μg/ml) for 8 h to inhibit JNK or RhoA, respectively. Cells were 
examined by confocal laser microscopy after immunostaining for E-cadherin 
(upper panel) or after staining for actin filaments with FITC-phalloidin (lower 
panel). Stained cells were examined by confocal laser microscopy. Scale bar, 
20 µm. (B) Cells were harvested by treating with dispase. Levels of JNK or 






Figure 6. The expression level of E- cadherin was not changed by the 
regulation of JNK activity. (A, B, C) E-cadherin expression was analyzed 
by Western blotting after treating cells with anisomycin (1 μM) (A) or after 















Figure 7. JNK, not ERK or p-38, regulates formation of intercellular E-
cadherin junctions. Cells were cultured in the presence of U0126 (10 μM), an 
ERK inhibitor, or SB203580 (15 μM), a p38 inhibitor, on fibronectin-coated 










Figure 8. The localization and expression level of odontogenic 
ameloblast-associated protein precursor (ODAM) in HOK-16B. (A) 
Decalcified paraffin sections of mandibular molars, including surrounding 
tissue, were examined by light microscopy (LM) or transmission electron 
microscopy (TEM) after HE or uranium/lead staining, respectively. ES 
indicates the empty space that appeared after complete decalcification of the 
enamel matrix. (B) TEM magnified the junctional epithelium (JE) and gingival 
epithelium (GE) shown as a box in Fig A. The upper part of the JE is 
surrounded by the GE in mice. Intercellular junctions within the JE were 
loosely formed, whereas intercellular junctions within the GE were tightly 
formed. Arrows indicate the intercellular spaces between the cells of the JE. 
* indicates the artificially separated gap between the JE and the GE. (C) ODAM 




Immunohistochemical staining of ODAM was performed to differentiate the JE 
from the GE. Decalcified sections of mandibular molars, including surrounding 
tissue, were immunostained using antibodies raised against ODAM. Nuclei 
were stained with DAPI. ES: enamel space, D: dentin, CT: connective tissue. 








Figure 9. Diagram of a hypothetical molecular mechanism in which cell 
attachment to a solid enamel surface leads to poorly formed intercellular 
junctions within the JE. JNK activated by RhoA, a result of cell attachment 
to solid surfaces such as enamel, may inhibit the development of E-cadherin 
junctions within the JE. In addition, this hypothetical mechanism suggests a 
possible role for bacteria in the regulation of these intercellular junctions 
through the modulation of RhoA activity. Furthermore, regulation of RhoA 
















Figure 10. Influence of JNK on ECJ development on rough surface. (A) 
HGKs were cultured on substrates with varying levels of roughness. The 
images were measured by immunocytochemical staining for the expression 
level of E-cadherin (red). F-actin (green) was stained with FITC-phalloidin. 
Nuclei were stained with DAPI (blue). The lower right picture in each set of 4 
pictures is a merged image of the E-cadherin, F-actin, and nuclei images. (B) 
HGKs were treated with SP (1 μM) to inhibit JNK activity for 24 hours in 
culture starting 12 hours after cell seeding on the smooth and rough substrates. 
CNT indicates the control culture without treatments with SP. (C) HGKs 
transfected using lentiviruses expressing shJNK1/2 to selectively inhibit 
JNK1/2 activity were re-plated for 24 hours on the rough substrate with low-
nanometer dimensions (Ra=121.3±13.4 nm). ECJ development was followed 
by immunocytochemical staining for the expression level of E-cadherin (red). 
F-actin (green) was stained with FITC-phalloidin. Nuclei were stained with 
DAPI (blue). The lower right picture in each set of 4 pictures is a merged 
image of the E-cadherin, F-actin, and nuclei images. shCNT, scrambled 








for 20 hours in culture starting 3 days after cell seeding on the rough 
substrates. CNT indicates the control culture without treatments with 
anisomycin (bar=20 μm). Ra=121.3±13.4, 505.3±115.3, and 867.0±168.6 
nm for R(4000), R(1200), and R(200), respectively. (E) Immunoblot assay 
was conducted in HGKs cultured on smooth(S) or rough (R: R#4000) for 24h. 
S: smooth substrate, SP: SP600125, JNK: c-Jun N-terminal kinase, ECJ: E-
cadherin junction, HGK: human gingival keratinocyte, CNT: carbon nanotube, 
Ra: average roughness, p-JNK: phospho-c-Jun N-terminal kinase, shRNA: 
small hairpin RNA, FITC: fluorescein isothiocyanate-labeled, DAPI: 4', 6-
diamidino-2-phenylindole dihydrochloride, R(4000): prepared with #4000 















Inherently up-regulated  
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i. INTRODUCTION  
 
The development of intercellular junctions is one of the most unique 
characteristics of epithelial cells. The destruction of intercellular junctions, an 
event that occurs in the epithelial-mesenchymal transition (EMT), results in 
the metastasis of epithelial cancer cells. Thus, the molecular mechanism by 
which the development of intercellular E-cadherin junction (ECJs) between 
epithelial cells is regulated has been intensely investigated. C-Jun N-terminal 
kinases (JNKs) regulate many physiological or pathological processes such as 
various stresses, inflammation, cell proliferation, differentiation, 
morphogenesis, cell migration, survival and death [47, 48]. Recently, it has 
been reported that JNKs are associated with the dissociation of epithelial cells. 
High JNK activity persistently induced by pharmacological drugs or 
constitutively induced by transfecting MKK4/7-JNK1/2 inhibits the 
development of ECJs between normal human skin keratinocytes [35]. The 
authors also reported that the development of ECJs of normal human oral 
keratinocytes is suppressed when JNK activity is constitutively up-regulated 
[49]. JNK mediates the disassembly of intestinal epithelia at apical junctions 
[50]. In addition, the metastasis of pancreatic cancer cells is promoted on type 
I collagen substrates through the up-regulation of JNK activity [51]. These 
previous reports suggest that epithelial carcinoma cells may grow scattered if 
their JNK activity is inherently up-regulated. 
YD-10B cells, which are established from human oral squamous carcinoma 
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cells developed in the male tongue, grow scattered without the development 
of ECJs, although they express epithelial markers such as E-cadherin and do 
not express mesenchymal markers such as vimentin [52]. The present study 
investigated whether JNK was associated with the scattered growth through 
suppressing the development of ECJs in these oral squamous carcinoma cells 
that maintained the molecular epithelial phenotype. The results of the present 
study may improve our understanding of the molecular mechanism by which 
epithelial carcinoma cells disassemble ECJs to dissipate, an event that occurs 




ii. MATERIALS AND METHODS  
 
1. Reagents and materials 
Antibodies for E-cadherin, c-Jun N-terminal kinase (JNK), phospho-c-Jun 
N-terminal kinase (p-JNK: Thr183/Tyr185), glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH), and horseradish peroxidase (HRP)-linked anti-
rabbit IgG were purchased from Cell Signaling Technology (Waltham, MA, 
USA). Cy3-conjugated anti-rabbit IgG antibody was obtained from Jackson 
ImmunoResearch (West Grove, PA). Fluorescein isothiocyanate-labeled 
phalloidin (FITC-phalloidin), 4′,6-diamidino-2-phenylindole 
dihydrochloride (DAPI), SP600125 (JNK inhibitor), anisomycin (JNK 
activator), and puromycin were obtained from Sigma-Aldrich (St. Louis, MO, 
USA). pcDNA3 Flag MKK7B2Jnk1a1 (constitutively active JNK1) and 
pCDNA3 Flag MKK7B2Jnk2a2 (constitutively active JNK2) were gifts from 
Roger Davis (Addgene plasmid # 19726, # 19727 respectively, Cambridge, 
MA) [53]. pCSCG was a gift from Inder Verma (Addgene plasmid # 12154) 
[54]. pCS-CG-MKK7B2Jnk1a1 and pCSCG-MKK7B2Jnk2a2 were 
generated by Cosmo Genetech (Seoul, Korea). The plasmids of JNK1/2 
shRNA (shJNK1/2) were purchased from Santa Cruz Biotechnology (Santa 
Cruz, CA). psPAX2 was a gift from Didier Trono (Addgene plasmid # 12260). 
pMD2.G was a gift from Didier Trono (Addgene plasmid # 12259). 
Lipofectamine LTX and Plus reagents were obtained from Invitrogen (Carlsbad, 
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CA). Transwell cluster plates (6.6 mm; 8.0-μm pore size) were purchased 
from Costar (Cambridge, MA). 
 
2.  Cell culture and transfection 
YD-10B and YD-8 cells, cell lines established from the biopsies of human oral 
squamous carcinoma cells, were obtained from SNU cell banks [52]. YD-10B 
and YD-8 cells were cultured in RPMI1640 (WELGENE, Gyeongsan-si, 
Korea). SCC-25 human squamous carcinoma cells were obtained from ATCC 
(Manassas, VA). SCC-25 cells were cultured in DMEM/F12 (WELGENE, 
Gyeongsan-si, Korea). HOK-16B cells, which are immortalized cells from 
periodontally healthy human retromolar gingival tissue, were a gift from Dr. 
N.-H. Park (School of Dentistry, University of California, Los Angeles, USA) 
[55]. HOK-16B cells were cultured in KGM keratinocyte growth medium 
supplemented with bovine pituitary extract, GA-1000 (gentamicin, 
amphotericin-B), hydrocortisone, rhEGF, insulin (recombinant human) (Lonza, 
Basel, Switzerland), and 1% penicillin. Cell transfection was performed as 
described previously [49]. Briefly, HEK 293T cells were transfected with 
pCS-CG-MKK7b2-JNK1a1, pCS-CG-MKK7b2-JNK2a2, or plasmids 
JNK1/2 shRNA (shJNK1/2), together with pMD2.G and psPAX2 to produce 
lentiviral particles using Lipofectamine LTX and Plus reagents. Next, the viral 
supernatants of HEK 293T cells were used to infect YD-10B cells. Cells were 
５０ 
 
selected by puromycin. Transfected cells expressed the green fluorescence 
protein (GFP) with varying intensities. 
 
3. Immunoblotting 
Immunoblotting was performed according to the standard protocol. Briefly, the 
cells were lysed with a lysis buffer (150 mM NaCl, 1% deoxycholate, 20 mM 
Tris-HCl (pH 7.5), 1 mM EDTA, 1% Triton X-100, 1 mM EGTA, 2.5 mM 
sodium pyrophosphate, 1 mM glycerophosphate) containing a protease 
inhibitor mixture consisting of 1 mM Na3VO4, 10 mM NaF, and 1 mM PMSF 
protease inhibitor (Boehringer, Mannheim, Indianapolis), 1 μg/ml leupeptin, 
and 1 μg/ml aprotinin phosphatase inhibitors (Calbiochem, La Jolla, CA). Cell 
lysates boiled in sample buffer were sizeseparated via SDS-PAGE and were 
transferred to polyvinylidene difluoride membranes. The membranes blocked 
with 5% skim milk were incubated with primary antibodies overnight at 4°C. 
Next, the membranes were incubated with secondary antibodies in 5% skim 
milk for 1 hr at room temperature. The blots were developed using enhanced 






Immunocytochemistry was performed according to the standard protocol. 
Briefly, cells were fixed with 4% v/v paraformaldehyde and were 
permeabilized in 0.5% v/v Triton X-100. The cells were incubated with 
primary antibody raised against E-cadherin at RT for 2 hrs. Next, the cells 
were treated with Cy3-conjugated anti-rabbit IgG antibody. F-actin was 
stained with FITC-phalloidin. Nuclei were stained with DAPI. Images of the 
stained cells were obtained using an LSM 700 confocal laser-scanning 
microscope (Zeiss, Oberkochen, Germany). In addition, images of Ecadherin 
and F-actin were merged to co-localize E-cadherin and F-actin. Quantitative 
data for the development of ECJ were obtained by dividing the total length of 
ECJ with the number of cells found in a picture taken by LSCM. Images were 
measured using ImageJ (NIH, Bethesda, MD.  
 
5. Migration assay 
Narrow scratches were made across the confluently grown cells using 
micropipette tips. Because YD-10B cells migrated highly rapidly, cell 
migration for 6 hrs was analyzed. Empty areas devoid of cells in the fixed area 
were measured using ImageJ on the images obtained by phase contrast 
microscopy because the migration front was not straight. The areas devoid of 
cells at 0 or 6 hrs were used to calculate the relative migration rates. Uniquely, 
the borders of the initially scratched areas were not discernible for YD-10B 
cells because they rapidly grew to mask the border line of the initial wounds 
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at 0 hrs. Thus, the average area free of cells at 0 hrs was used as an area at 
0 hrs in the calculation of the migration rates. The migration rate was 
calculated as follows: Migration rate = (average area free of cells at 0 hrs – 
area devoid of cells at 6 hrs) / average area free of cells at 0 hrs. 
 
6. Statistical analysis 
Statistical analyses were performed using MedCalc version 17.2 for Windows 
(MedCalc software, Ostend, Belgium). Statistical analyses were performed to 
compare the two groups using independent samples t-test when the data were 
in normal distribution or the Mann-Whitney test when the data were not in 
normal distribution. To compare more than two groups, one-way analysis of 
variance was used when the data were in normal distribution, and the Kruskal-
Wallis test was used when the data were not in normal distribution. Post hoc 
tests for pairwise comparisons were analyzed using the Tukey-Kramer test 
after one-way analysis of variance and the Mann-Whitney test after the 






iii. RESURLTS AND DISCUSSION 
 
YD-10B cells expressed a high level of epithelial markers such as E-cadherin 
as normal oral keratinocytes, HOK-16B cells, and did not express 
mesenchymal markers such as vimentin and N-cadherin, which were 
expressed in other squamous carcinoma cells such as SCC25 and YD-8 cells 
(Fig 11A) [56-60]. This epithelial phenotype of YD-10B cells devoid of 
mesenchymal markers suggests that they are at the early phase of 
transformation. Unexpectedly, however, YD-10B cells grew scattered without 
the development of ECJs on substrates used for cell culture and showed a high 
migration rate as other mesenchymal squamous carcinoma cells, such YD-8 
cells (Fig 11B). The scattering of YD-10B cells was confirmed on the 
substrates that were pre-coated with a definite amount of fibronectin on the 
hydrophobic dishes (Fig 11C). YD-10B cells scattered on the substrates 
where HOK-16B normal keratinocytes or SCC-25 epithelial tumor cells 
aggregated. The scattered growth of YD-10B cells was remarkable in that 
they definitely maintained the epithelial phenotype and did not express 
mesenchymal markers. We noticed that the expression level of p- JNK was 
up-regulated in YD-10B cells compared to epithelial HOK-16B or SCC-25 
cells (Fig 1A). JNK has been reported to be associated with the development 
of E-cadherin junctions in normal or tumor epithelial cells [35, 50, 51]. JNK 
activity is associated with the development of ECJs in normal human skin 
keratinocytes. In addition, apical junctions are disassembled by activating JNK 
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in intestinal epithelia. Some tumor cells dissociate on the collagen matrix 
through the up-regulation of JNK activity. Recently, we reported that JNK 
activity is detrimental to the development of ECJs in normal human oral 
keratinocytes [49]. Thus up-regulated expression of p-JNK was further 
investigated whether it was associated with the scattering of YD-10B cells. 
 
The up-regulated JNK activity of YD-10B cells was suppressed to examine 
whether downregulated 
JNK activity reversed the scattered growth of the cells through inducing the 
development of ECJs. Lowered JNK activity, by treating cells with SP600125, 
a pharmacological JNK inhibitor, aggregated cells with the development of 
ECJs (Fig 12A). Knock-down of JNK1/2, by transfecting the cells with 
shJNK1/2 lentiviral supernatant produced in HEK 293T cells, also induced the 
development of ECJs in YD-10B cells (Fig 12B). These results indicate that 
YD-10B cells grow scattered due to the inherently up-regulated JNK activity. 
It is interesting that carcinoma cells dissociate due to the change in a single 
modality, JNK activity, despite the high expression of E-cadherin. 
Furthermore, inhibiting JNK activity significantly suppressed cell migration, 
which is critical in the dissipation of cancer cells (Fig 12C). Cohesive growth 
of the tumor cells following the development of E-cadherin junctions may slow 
down the outward migration of the tumor cells. Interestingly, the p-JNK level 
of YD-10B cells varied depending on the adhesion strength of the cells to the 
substrates (Fig 13A). According to the decreasing amount of pre-coated 
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fibronectin before cell seeding, the expression of p-JNK was tentatively 
decreased concomitant with the interim decrease in cell scattering along with 
the increase in the development of E-cadherin junctions, although the cells 
momentarily scattered after culture for 2 days. In addition, the expression 
level of p-JNK was remarkably low, and E-cadherin junctions were obviously 
developed in the cells cultured at high density, allowing unconstrained physical 
cell contacts (Fig 13B). These results indicate that E-cadherin of YD-10B 
cells is functionally intact and, more importantly, confirm that the expression 
level of p-JNK is associated with the development of E-cadherin junctions in 
YD-10B cells. However, it was uncertain whether cell contacts lowered the 
expression of p-JNK or the lowered expression of p-JNK promoted the 
development of E-cadherin junctions. To solve this issue, YD-10B cells in 
which JNK activity was consistently up-regulated using anisomycin, a 
pharmacological JNK activator, or was constitutively activated by transfecting 
MKK7-JNK1/2, were examined to determine whether JNK activity inhibited 
the development of E-cadherin junctions or destroyed the pre-developed E-
cadherin junctions in cultures on substrates pre-coated with a low amount of 
fibronectin or cultures at a high density to force physical contacts. YD-10B 
cells in which JNK activity was persistently or constitutively activated 
apparently did not develop E-cadherin junctions despite the culture conditions 
inducing the development of E-cadherin junctions to our suggestions (Figs 
14A - C). The E-cadherin junctions of YD-10B cells that were cultured at 
confluency did not develop when JNK was constitutively activated by 
５６ 
 
expressing the MKK7-JNK1/2 fusion protein using lentiviral vectors (Fig 
14A). E-cadherin junctions that had developed by culturing the cells to 
confluence were disassembled to create intercellular gaps by pharmacological 
JNK activation with anisomycin treatment (Fig 14B). In addition, E-cadherin 
junctions developed on substrates pre-coated with a low amount of fibronectin 
were also destroyed to generate intercellular gaps by persistent JNK 
activation with anisomycin treatment (Fig 14C). These results further confirm 
that YD-10B cells grow scattered due to the high JNK activity, although they 
maintain the epithelial phenotype, such as the expression of functional E-
cadherin. The involvement of inherent JNK activity in the destruction of the 
cell-cell junctions in epithelial carcinoma cells demonstrated in the present 
study has not been reported to our limited knowledge, although inherently 
activated JNK is associated with other events related to tumorigenesis in some 
cancer cells. The role of hepatocellular carcinoma cells or prostate cancer cells 
that are high in the activity or expression level of JNK has been reported to 
be associated with events other than the dissociation of the cell-cell junction 
[61-65]. 
Next, we noticed the up-regulated expression of p-JNK in YD-10B cells 
compared to HOK-16B cells or SCC-25 cells on the same substrates where 
YD-10B cells scattered but HOK-16B cells or SCC-25 aggregated (Fig 11). 
These findings propose a possibility that the pathway activating JNK 
depending on adhesion signaling to the substrates may be associated with the 
dissociation of the ECJs in YD-10B cells (Fig 13A). If this is the case, 
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extraordinarily up-regulated p-JNK may dissociate and dissipate YD-10B 
cells through the matrix of tissues which does not induce the scattering of 
other carcinoma cells such as SCC-25 cells in which JNK activation is less 
responsive to adhesion signaling. Further study regarding the signaling 
pathway associated with the hyper responsiveness of squamous carcinoma 
cells to adhesion signaling in the activation of JNK may improve our 
understanding of the molecular mechanism by which epithelial carcinoma cells 
disassemble the E-cadherin junctions to dissipate, an event that occurs in the 
early phase of tumorigenesis. In summary, the present study demonstrated 
that YD-10B cells lose epithelial cohesiveness due to the inherently up-
regulated JNK activity, despite their high expression of functional E-cadherin, 
which is the pre-requisite for the transformation of the epithelial tumor cells 
to mesenchymal cancer cells. The present study also shows that the 
suppression of JNK activity restores their epithelial growth through 
developing E-cadherin junctions. However, further study is required to 
investigate what inherently up-regulates JNK activity at the early stage of the 
tumorigenic process while they highly express functional E-cadherin. Oral 
squamous carcinoma-derived YD-10B cells may be a model cell line for such 
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Figure 11. Phenotypes of the HOK-16B normal human oral keratinocyte 
cell line and various squamous cell carcinoma cell lines (SCC25, YD-
10B, YD-8) derived from oral keratinocytes. (A) Various cells were 
cultured routinely in cell culture dishes for 24 hrs. Next, the expression levels 
of E-cadherin, vimentin, N-cadherin, and p-JNK were compared by 
immunoblotting methods. (B) Various cells were cultured routinely on cell 
culture dishes for 24 hrs. The cells were then observed by phase contrast 
microscopy or CLSM after staining E-cadherin (Red) by immunocytochemical 
methods or staining F-actin (Green) with FITC-phalloidin. Merged images of 
E-cadherin and F-actin were over-exposed to co-localize them. Nuclei were 
stained with DAPI. Cell migration was assayed using transwell cluster plates. 
Cells placed on the upper surface of the filter in chambers were incubated at 
37°C for 24 hrs. Next, the cells migrated through the filter were recorded 
after staining. Original magnification of phase contrast microscopic images: 
×100. (C) Various cells were cultured on hydrophobic dishes that were pre-
coated with fibronectin (0.2 μg/cm2) for 24 hrs. Next, the cells were 
observed by CLSM after staining E-cadherin (Red) by immunocytochemical 








Figure 12. Effects of lowered JNK activity on E-cadherin junctions and 
cell migration of YD-10B cells. (A) YD-10B cells cultured for 18 hrs were 
further cultured routinely in cell culture dishes with SP600125 (SP) (5 μM) 
for 20 hrs to suppress the activity of JNK. Next, cells were observed by phase 
contrast microscopy or CLSM after staining E-cadherin (Red) by 
immunocytochemical methods. A lowered expression level of p-JNK by SP 
treatments was confirmed by immunoblotting methods. Statistical analysis was 
performed using independent sample t-test because the data were in normal 
distribution. Bar plot (mean ± SD). *p < 0.05, n = 3 and 4 for NT and SP, 
respectively. NT: control culture without SP600125. Arrows: E-cadherin. 
Scale bar: 20 μm. Original magnification of phase contrast microscopic images: 
×100. (B) YD-10B cells were transfected with the supernatant of HEK 293T 
cell cultures producing lentiviral particles containing JNK shRNA for 2 days. 
Next, cells were selected by puromycin and replated on the cell culture dishes. 
Transfected cells were observed by phase contrast microscopy or CLSM after 
staining E-cadherin (Red) by immunocytochemical methods after culture for 
24 hrs. A lowered expression level of p-JNK by transfecting shJNK was 
confirmed by immunoblotting methods. Statistical analysis was performed 
using one-way analysis of variance followed by post hoc analysis of the 
Tukey-Kramer test for pairwise comparisons because the data were in normal 
distribution. Bar plot (mean ± SD). *p < 0.05 (n = 2, 2, and 3 for shCont, 
shJNK1, and shJNK2, respectively). shCont: scramble shRNA. Arrows: E-
cadherin. Scale bar: 20 m. Original magnification of phase contrast 
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microscopic images: × 100. (C) YD-10B cells were cultured to confluency for 
48 hrs. Next, the cells were treated with SP (5 μM) for 6 hrs after scratching 
to detach the cells from the culture surfaces. The migration rates were 
assessed by the methods described in the Materials and Methods section. 
Statistical analysis was performed using non-parametric Mann-Whitney test 
because the data were not in normal distribution. Box-and-Whisker plot (the 
centerline: median). *P < 0.05, n = 15 and 16 for CNT and SP respectively. 

















Figure 13. Effects of the culture conditions of YD-10B cells with varying 
adhesion strengths to the substrates or cell density on the development 
of E-cadherin junctions. (A) YD-10B cells were cultured on hydrophobic 
culture dishes pre-coated with varying amounts of fibronectin (FN) for 24 hrs. 
Fibronectin was pre-coated on hydrophobic polystyrene dishes at 37°C for 
2 hrs. The dishes were then blocked with 5% BSA for 1 hr at 37°C. (B) YD-
10B cells were cultured routinely in cell culture dishes at low confluency 
(loose) or at confluency to induce physical contact (dense) for 24 hrs. (A - 
Β) Cells were observed using phase contrast microscopy (upper lane) or 
CLSM (mid lane) after staining E-cadherin (Red) by immunocytochemical 
methods. The expressions levels of p-JNK in YD-10B cells were examined 
by immunoblotting methods after cell culture for 24 hrs, respectively. Arrows: 
E-cadherin. Scale bar: 20 μm. Original magnification of phase contrast 










Figure 14. Effect of the constitutive JNK activation on the development 
of E-cadherin junctions in YD-10B cells. (A) YD-10B cells in which JNK 
expression was constitutively activated by the supernatant of HEK 293T cell 
cultures producing lentiviral particles containing plasmid for MKK7-JNK1/2 
expression were selected with puromycin for 2 days. Next, the selected cells 
were cultured routinely for 3 days in cell culture dishes to confluency to induce 
the development of E-cadherin junctions. Control (NT) dishes were incubated 
with the supernatant of HEK 293T cell cultures producing lentiviral particles 
devoid of plasma for MKK7-JNK1/2 expression. Cells were observed by 
CLSM after staining E-cadherin (Red) by immunocytochemical methods and 
nuclei (blue) with DAPI. Green: Exogenous GFP. Pictures at the bottom right 
are the merged images of E-cadherin, exogenous GFP, and nucleus. The 
expression levels of p-JNK (fusion proteins and endogenous proteins) were 
confirmed by immunoblotting p-JNK. (B) YD-10B cells were treated with 
anisomycin (50 ng/ml) to disrupt E-cadherin junctions through activating JNK 
for 16 hrs when cells reached confluence on cell culture dishes for 24 hrs. 
Intercellular gaps (arrows). (C) YD-10B cells were treated with anisomycin 
(50 ng/ml) for 24 hrs to disassemble the E-cadherin junctions through 
activating JNK for the cells cultured on the substrates pre-coated with a low 
amount of FN (0.04 μg/cm2) for 20 hrs. The increased level of expression of 
p-JNK by treating cells with anisomycin was confirmed by immunoblotting p-
JNK. Intercellular gaps (arrows). (B - C) Cells were observed by CLSM after 
staining E-cadherin (Red) by immunocytochemical methods or staining F-
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actin (Green) with FITC-phalloidin. The pictures at the bottom right are 


















From the results of the present study, it is indicated that the decreased 
formation of intercellular E-cadherin junctions between human gingival 
keratinocytes may be coupled to high RhoA-JNK activity. The present study 
also clearly demonstrates that JNK activity is closely associated with adhesion 
condition of oral keratinocytes to the substrates such as substrate pliability, 
substrate roughness, and adhesion strength. In addition, JNK characteristically 
over-stimulated on the substrates of much low adhesion strength induces the 
scattered growth of the oral squamous cell carcinoma cells through down-
regulating the development of E-cadherin junctions despite the expression of 
















Figure 15. Summary of the findings. A) Substrate pliability, substrate 
roughness, and adhesion strength regulates the JNK activity which dissociates 
the E-cadherin junction of oral keratinocytes. B) Transformed cells 
characteristically over-stimulated JNK activity on the substrates of much low 
adhesion strength, which induces the scattered growth of the oral squamous 
cell carcinoma cells through down-regulating the development of E-cadherin 
junctions despite the expression of functional E-cadherin, a hallmark of the 
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ABSTRACT IN KOREAN 
국문 초록 
 
치은열구 상피를 포함하여 대부분의 구강상피는 상피의 대표적 특성인 E-
cadherin 결합이 잘 발달된 반면에 치은염과 치주염과 밀접한 관계가 있는 치은 
접합상피(junctional epithelium)는 E-cadherin 결합의 발달이 미약하다. 따라서 
구강상피의 E-cadherin 결합을 조절하는 기전을 이해하는 것은 병리생리학적으
로 구강상피를 이해하는 데에 필수적이라 할 수 있다. 그러나 구강상피세포에서 
E-cadherin 결합의 조절기전은 아직 잘 알려져 있지 않다. HOK-16B 치은각화
상피세포주를 사용하여 구강각화상피 E-cadherin 결합 조절의 분자기전을 연구
하였다. 구강상피세포의 E-cadherin 결합은 c-Jun N-말단 인산화효소(JNK)의 
자극에 의해 발달이 억제되었으며 JNK 억제에 의해 발달이 촉진되었다. 이와 같
이 구강각화상피의 E-cadherin 결합 발달을 억제하는 JNK는 small GTPase 
RhoA(RhoA)에 자극에 의해 p-JNK 발현이 증가하였고, RhoA 활성 억제에 의
해 p-JNK 발현이 억제되었다. 이상의 결과는 구강각화상피세포의 E-cadherin 
결합의 발달이 RhoA-JNK 신호전달에 의해 조절됨을 가리킨다. 한편, 접합상피
는 다른 치은상피에 비해 미약한 E-cadherin 발현과 높은 p-JNK 발현을 보였
는데, 이는 접합상피의 미약한 E-cadherin 결합의 발달이 p-JNK의 높은 발현
과 연관되어 있을 가능성을 가리킨다. 상피성 종양세포가 세포간 결합을 상실하고 
흩어지는 기전은 종양 발달의 초기 단계를 이해하는데 중요하다. 이에 E-
cadherin을 발현하지만 일반 배양 조건에서 흩어져 증식하는 구강편평상피암세포
주인 YD-10B 세포를 이용하여 구강편평세포암세포에서도 정상구강각화상피세포
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와 마찬가지로 JNK에 의해 E-cadherin 결합의 발달이 조절되는지 연구하였다. 
YD-10B 세포는 정상세포인 HOK-16B 세포가 흩어지는 fibronectin 도포 기질
조건뿐만 아니라, 응집하여 세포결합을 형성하는 fibronectin 도포 조건 중 최대
량의 fibronectin이 도포된 조건에서도 p-JNK가 강하게 발현하고 흩어져 증식하
였다. 이와 같은 YD-10B 세포는 응집하는 극히 적은 양의 fibronectin 도포 기
질 조건일지라도 JNK 활성을 자극하면 흩어졌고, 흩어지는 fibronectin 도포 기
질 조건에서도 JNK 활성을 억제하면 응집하였다. 이상의 결과는 YD-10B 구강
편평세포암세포가 기능적인 E-cadherin 발현의 상실의 결과가 아니라 JNK 활성
에 의해 E-cadherin 결합의 발달이 억제됨을 가리킨다. 더불어서 이 결과는 
YD-10B 암세포의 JNK 활성이 HOK-16B 정상 세포의 JNK 활성화 기질 부착
조건보다 약한 기질 부착 조건에서도 높게 활성화 되어 E-cadherin 결합 발달을 
억제함으로써 YD-10B 세포가 정상세포와 달리 미약한 부착기질 조건에서도 흩
어져 증식할 수 있음을 가리킨다. 이상의 결과로서 본 연구는 HOK-16B 정상구
강각화상피세포와 YD-10B 구강편평세포암세포 모두 JNK 신호전달에 의해 E-
cadherin 결합이 조절되어 세포간 결합이 저해될 수 있음을 보여 주었다. 
―――――――――――――――――――――――――――――――――――――― 
주 요 어: E-cadherin, JNK, RhoA, 정상 구강잇몸세포, 구강편평상피암세포. 
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